SEPTEMBER - 20235TECH OUTLOOKCXO INSIGHTSCXO INSIGHTSC O NT E NT SHow CMOs/CDMOs can Add Value for Pharma CompaniesOzgur Akbulut, Director, Global Divestments and Contract Manufacturing Lead, Takeda [NYSE:TAK]28The Evolution of Biomanufacturing: Insights into Post-COVID Industry DynamicsOliver Vogt, VP Manufacturing Operations, Multi-Site, Emergent BioSolutions20Facilitating a Lessons Learned Session with your CMOYvonne Ware, Associate Director, Manufacturing Operations, BioNTech SE18Complexities in the Development Process for Pharmaceutical ManufacturingErik Lemay, Head of Global External Manufacturing, Servier26The Tipping Point for Scalable Manufacturing Processes to Pivot Gene TherapiesDr Linda Randall, AVP Biologics Manufacturing & Control, Pharmarons Gene Therapy24Growing demand for More Specialized Services Specialized Services: A New Paradigm in TherapeuticsBrian Fry, Director, Global Cell Therapy, Charles River Laboratories22The Growing Importance of CDMOs16
< Page 4 | Page 6 >